A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States.
暂无分享,去创建一个
J J Prete | W S Bice | B R Prestidge | P. Grimm | J. Friedland | R. Stock | B. Prestidge | J. J. Prete | W. Bice | R G Stock | P D Grimm | J L Friedland
[1] S Nag,et al. Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. , 1995, Urology.
[2] P. Unger,et al. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma , 1996, Cancer.
[3] K. Wallner,et al. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. , 1996, International journal of radiation oncology, biology, physics.
[4] J Roy,et al. Treatment-related symptoms during the first year following transperineal 125I prostate implantation. , 1994, International journal of radiation oncology, biology, physics.
[5] R. Stock,et al. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. , 1996, International journal of radiation oncology, biology, physics.
[6] J. Blasko,et al. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer. , 1997, International journal of radiation oncology, biology, physics.
[7] H. Holm,et al. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. , 1983, The Journal of urology.
[8] J. Roy,et al. Short-term freedom from disease progression after I-125 prostate implantation. , 1994, International journal of radiation oncology, biology, physics.
[9] Blasko,et al. Brachytherapy and Organ Preservation in the Management of Carcinoma of the Prostate. , 1993, Seminars in radiation oncology.
[10] J. Blasko,et al. Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma. , 1995, The Journal of urology.
[11] L. Anderson,et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .
[12] J Roy,et al. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] F. Shamsa,et al. Regarding, Dattoli, Wallner, Sorace, Koval, Cash, Acosta, Brown, Etheridge, Binder, Brunelle, Kirwan, Sanchez, Stein, and Wasserman IJROBP 35(5):875-879; 1996. , 1997, International journal of radiation oncology, biology, physics.
[14] B. Prestidge,et al. Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine. , 1998, International journal of radiation oncology, biology, physics.